THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES

Header Logo

Connection

Laura Holman to Poly(ADP-ribose) Polymerase Inhibitors

Back to Details
This is a "connection" page, showing publications Laura Holman has written about Poly(ADP-ribose) Polymerase Inhibitors.
Laura Holman
Connection Strength
0.224
Poly(ADP-ribose) Polymerase Inhibitors
  1. Niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer: final overall survival results from the PRIMA/ENGOT-OV26/GOG-3012 trial. Ann Oncol. 2024 Nov; 35(11):981-992.
    View in: PubMed
    Score: 0.224
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES